Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
HIPPO (sudeng) fluctuates 42.5% in 24 hours: trading volume surges to nearly $2 million

HIPPO (sudeng) fluctuates 42.5% in 24 hours: trading volume surges to nearly $2 million

Bitget PulseBitget Pulse2026/05/09 15:57
Show original
By:Bitget Pulse

Volatility Overview

In the past 24 hours, HIPPO's price rebounded from a low of $0.000200 to a high of $0.000285 and is currently quoted at $0.000242, with an overall amplitude of 42.5%. The 24-hour trading volume surged to approximately $1.93–2.02 million, and market capitalization is about $2.4 million, showing a slight increase compared to the previous day.

Brief Analysis of Abnormal Volatility

- Trading volume skyrocketed by 116%–142% within 24 hours (peaking at $2.89 million), and the high turnover rate (about 1.4 times the market cap) directly amplified price volatility, confirming strong capital inflows.

- No official announcements or large on-chain whale transfers were recorded; the volatility mainly stems from typical high-volume speculative activity driven by meme coins.

Market Perspectives and Outlook

Community sentiment is slightly positive-neutral, with the average score on social media at 2.5/5. Discussions on Binance Square indicate that “buying pressure has picked up after a healthy correction.” Mainstream views point out high volatility risks; the market may continue to see price-volume linkage, but without catalysts, a correction is likely.

Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational reference only.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Asian stock markets collectively declined, South Korean stocks plunged 4.5%, Japanese stocks fell over 1%, and SK Hynix dropped 7%.

All major stock indices in South Korea fell by more than 4%, leading declines in Asia-Pacific markets. SK Hynix plunged over 7%, approaching its lowest point since April. Samsung Electronics fell by more than 3%. The Nikkei 225 dropped 1%, and the TOPIX fell by about 0.9%. SoftBank Group plummeted 6.34%. The MSCI Asia-Pacific Index dropped by about 1%, with eight out of eleven sub-industries recording losses; the number of declining stocks was roughly three times that of advancing stocks. Gold extended its overnight losses, falling another 0.34%.

华尔街见闻•2026/10/20 02:22

Deja vu? After another blow to the "AI stock god," AI trading sees a rebound

Goldman Sachs has upgraded CoreWeave’s rating, with several analysts expressing strong support for its fundamentals, alleviating fears of "AI capital expenditure peaking." The Philadelphia Semiconductor Index ended its eight-day losing streak and closed up 1.6%. Previously, "AI stock guru" Aschenbrenner suffered severe losses again, with the average decline of his top seven holdings reaching 18.3%.

华尔街见闻•2026/10/20 02:07

Wall Street collectively rushes to "extinguish panic" over CoreWeave: Don't use one company to negate the entire AI cycle!

Barclays pointed out that CoreWeave's approximately $1.5 billion unsecured bonds account for a very small portion of its total $35 billion debt, yet the market is treating them as a barometer for the entire AI capital expenditure cycle. This is similar to how, during the 2023 Silicon Valley Bank crisis, the $4 billion regional bank ETF was used to predict a U.S. recession. Goldman Sachs believes that the market is using the wrong benchmark, noting that unsecured bonds do not represent the real incremental financing cost. JPMorgan states that banks' exposure is secured and the risks are controllable.

华尔街见闻•2026/10/20 01:52
Wall Street collectively rushes to "extinguish panic" over CoreWeave: Don't use one company to negate the entire AI cycle!

Morgan Stanley Covers Eight Biotech Companies at Once! PTC Therapeutics (PTCT.US) and Belite Bio (BLTE.US) Receive Positive Outlook, Multiple Potential Blockbuster Drugs Highlighted

Morgan Stanley recently released a research report covering eight biotechnology companies for the first time, whose businesses involve rare diseases, ophthalmology, pulmonary diseases, and neuropsychiatric disorders.

智通财经•2026/10/20 01:51